Senior Correspondent, London
Ben's Feed
Oct 7, 2014
Oct 6, 2014

Nobel discovery opens window onto Alzheimer’s disease

LONDON (Reuters) – The discovery of cells in the brain that act as the body’s internal global positioning system, which won three scientists the Nobel Prize for medicine on Monday, opens an intriguing new a window onto dementia.

Since these spatial cells are among the first to be hit in Alzheimer’s and other forms of dementia — explaining why sufferers often lose their way — understanding how they are degraded should shed important light on the disease process.

Oct 6, 2014
Oct 6, 2014
Oct 2, 2014
Oct 2, 2014

EU agency adopts plan to cut clinical trial secrecy

LONDON, Oct 2 (Reuters) – Europe’s medicines regulator has
endorsed a scheme to publish detailed clinical reports
underpinning new drug approvals from next year, though
campaigners for full transparency said they were concerned some
data would still be missing.

The London-based European Medicines Agency (EMA) has been at
the centre of a row about divulging trials data for the past two
years, following concerns over undisclosed data for certain
drugs such as Roche’s flu pill Tamiflu.

Oct 2, 2014
Oct 1, 2014
Oct 1, 2014
Oct 1, 2014
    • About Ben

      "Ben Hirschler is European pharmaceuticals, biotechnology and healthcare correspondent, based in London. Previously, he was in charge of British company news and before that was posted to Johannesburg, covering the economic challenges facing post-apartheid South Africa."
    • More from Ben

    • Follow Ben